$OPCH

Option Care Health (OPCH) Reports Earnings Tomorrow: What To Expect

Option Care Health (OPCH) is scheduled to report earnings Wednesday morning. Last quarter, it posted revenue of $1.35B, up 1.3% YoY, but missed analysts’ revenue expectations. Full-year revenue guidance missed expectations while EBITDA guidance met. Analysts expect this quarter’s revenue to be flat YoY; the average price target is $28.08 vs $21.65.

Original reporting
Published Jul 28, 2026, 3:19 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 28, 2026, 4:23 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Option Care Health (OPCH) Reports Earnings Tomorrow: What To Expect — source image
Decision brief

The 30-second read

$OPCHNeutralMed
01

Why it matters

Traders are positioned for a revenue print near flat YoY, with the key risk being whether full-year guidance (especially EBITDA) confirms or resets expectations.

02

Market read

Earnings preview with specific prior-quarter revenue and guidance context, plus consensus expectations for the upcoming quarter.

03

What to watch

The piece does not quantify margin, cash flow, or guidance drivers; traders should focus on those items in the actual earnings release rather than the revenue headline.

Relevance 5/10Novelty 5/10Timing: ahead of Wednesday morning earnings release

Background

The article previews Option Care Health’s upcoming earnings and summarizes the prior quarter’s revenue and guidance performance versus analysts.

Company-level read

Ticker impact

$OPCHNeutralMedium confidence
Context

Option Care Health is set to report earnings Wednesday morning, with prior-quarter revenue and guidance details shaping expectations into the print.

Expected impact

Near-term volatility likely around revenue/guidance versus consensus; direction depends on whether full-year EBITDA or revenue guidance beats or misses.

Evidence & confidence

The newest concrete facts are the upcoming earnings timing plus last quarter’s revenue miss and guidance outcomes, which directly inform what traders will watch for in the upcoming release.

Market effects

Provides a read-through for healthcare providers and services earnings season, referencing peer results but without new sector data.

No explicit regional impact described.

No explicit global linkage described.

Counterpoint

Even with revenue consensus stability, the stock can re-rate sharply if full-year EBITDA guidance or margin commentary diverges from expectations.

Key entities

  • Option Care Health

    OPCH, the subject company reporting earnings Wednesday morning.

  • Tenet Healthcare

    Peer cited for Q2 revenue growth and post-results stock reaction.

  • UnitedHealth

    Peer cited for flat revenue and post-results stock reaction.

Related articles

$OPCHMed

Option Care Health, Inc. Q2 2026 Earnings Call Summary

Strategic Execution and Portfolio Recovery Performance beat driven by high-single-digit organic growth in the acute portfolio, where the company's national scale and local responsiveness facilitate time-sensitive hospital discharges. The chronic inflammatory disease (CID) portfolio reached a stabilization point following a first-quarter reset, with patient census beginning to rise sequentially despite biosimilar pricing headwinds.

$OPCHMedAI 8/10

Option Care Health (NASDAQ:OPCH) Posts Better

Option Care Health (OPCH) reported Q2 CY2026 revenue of $1.44 billion, up 1.9% year over year, beating Wall Street’s expectations. The company guided full-year revenue to about $5.73 billion. Non-GAAP profit was $0.45 per share, 5.4% above consensus. Shares rose about 6.5% to $23.95 after the release.

$OPCHMed

Option Care Health, Inc. (OPCH): Results of Operations and Financial Condition

Option Care Health, Inc. (OPCH) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 exhibit991-q22026.htm EX-99.1 Document Exhibit 99.1 OPTION CARE HEALTH ANNOUNCES FINANCIAL RESULTS FOR THE SECOND QUARTER ENDED JUNE 30, 2026 BANNOCKBURN, IL., July 29, 2026 - Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s

$OPCHMed

Option Care Health (OPCH) Stock Trades Up, Here Is Why

Option Care Health shares rose about 3.7% in the morning after Goldman Sachs initiated coverage with a Neutral rating and a $22 price target, implying upside from around $20.51. The stock had fallen 33% over six months. The article notes the company recently reported Q1 2026 revenue of $1.35B (+1.3% YoY) and cut full-year revenue guidance to a $5.73B midpoint.

$WHRMed

Whirlpool Q2 Earnings Call Highlights

Whirlpool (NYSE:WHR) reported Q2 earnings call updates. North America industry demand fell 3.4% YoY, but Whirlpool said it held market share. The company raised promotional pricing by over 10% in late April and expects further margin improvement in Q3. It targets $150M cost reductions in 2026, including $60M automation, and guided FY revenue up ~1.5% and FCF of ~$300M.

$WATMedAI 8/10

Waters Q2 Earnings Call Highlights

Waters (NYSE:WAT) reported Q2 updates from its earnings call. Materials Science Division revenue rose to $87M. Biosciences and Diagnostic Solutions acquired from BD generated $817M revenue. Waters raised FY organic constant-currency growth outlook to 7% to 9%, projecting FY reported revenue of $3.370B to $3.431B and adjusted EPS of $14.45 to $14.65.